Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value
$910.84M
Total Bought
$105.72M
Total Sold
$107.42M
Net Transaction
-$1.69M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
CENTURY THERAPEUTICS INC(IPSC)05,410,361+5,410,361013,7961.51%+13,796
NUVALENT INC2,697,2672,697,2670202,538204,61522.46%+2,077
TANGO THERAPEUTICS INC(TNGX)2,892,6632,892,663022,96824,8192.72%+1,851
XILIO THERAPEUTICS INC(XLO)2,805,4133,785,450+980,0373,0303,5870.39%+557
NEWAMSTERDAM PHARMA COMPANY
*W EXP 99/99/999
100,000100,00001,1048720.10%-232
SYROS PHARMACEUTICALS INC2,749,8082,749,808014,71114,1891.56%-522
DISC MEDICINE INC(IRON)1,317,2131,795,735+478,52282,01080,9348.89%-1,076
NAUTILUS BIOTECHNOLOGY INC(NAUT)2,000,0002,000,00005,8804,6800.51%-1,200
ATEA PHARMACEUTICALS INC(AVIR)2,485,6382,485,638010,0428,2270.90%-1,815
RAPID MICRO BIOSYSTEMS INC(RPID)8,434,5608,434,56008,1825,5670.61%-2,615
ACLARIS THERAPEUTICS INC(ACRS)3,000,0001,000,000-2,000,0003,7201,1000.12%-2,620
C4 THERAPEUTICS INC(CCCC)1,142,2101,111,910-30,3009,3325,1370.56%-4,195
INVIVYD INC(IVVD)1,799,5951,799,59507,9901,9800.22%-6,011
MARINUS PHARMACEUTICALS INC1,393,3802,267,680+874,30012,5962,6530.29%-9,943
ARCUTIS BIOTHERAPEUTICS INC(ARQT)2,011,6871,030,703-980,98419,9369,5861.05%-10,350
DIANTHUS THERAPEUTICS INC(DNTH)2,992,0283,013,423+21,39589,76177,9878.56%-11,773
X4 PHARMACEUTICALS INC(XFOR)16,915,78416,915,784023,5139,8111.08%-13,702
SAVARA INC(SVRA)14,565,45714,565,457072,53658,6996.44%-13,837
PHARVARIS N V
COM
3,303,3813,303,381076,34162,1046.82%-14,238
CABALETTA BIO INC(CABA)1,617,3641,649,964+32,60027,59212,3421.35%-15,250
NURIX THERAPEUTICS INC(NRIX)1,132,3970-1,132,39716,6460—-16,646
ANNEXON INC(ANNX)8,703,2688,449,208-254,06062,40241,4014.55%-21,001
MERSANA THERAPEUTICS INC8,663,6738,663,673038,81317,4141.91%-21,399
SOLID BIOSCIENCES INC4,034,5824,034,582053,74122,8762.51%-30,865
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
10,473,91310,473,9130247,708201,20422.09%-46,504
MADRIGAL PHARMACEUTICALS INC(MDGL)196,9950-196,99552,6060—-52,606
KYVERNA THERAPEUTICS INC(KYTX)3,163,8683,368,370+204,50278,59025,2632.77%-53,328
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q2 2024 | TickerTrail